Extend telehealth flexibilities to virtual prescribing, mental health services, coalition asks lawmakers
By
Kimberly Bonvissuto
Sep 16, 2024
A coalition of provider and consumer organizations is asking policymakers to extend telehealth flexibilities related to virtual prescribing tied to mental health services.
Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Semaglutide reduces risk for MACE in patients with obesity and heart failure
By
Haymarket Media
Aug 28, 2024
MACE, heart failure composite end point, cardiovascular death and all-cause death all improved with semaglutide for patients with versus without heart failure.
Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
ACC: Empagliflozin cuts heart failure hospitalization risk after AMI
Apr 08, 2024
Lower risks for first heart failure hospitalization and total heart failure hospitalization were seen with empagliflozin.
Cyberattack stalls prescription dispensing at UnitedHealth
Feb 27, 2024
This latest cyberattack underscores the vulnerability of healthcare data, particularly the privacy of patients’ personal information.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
PointClickCare announces multiple new tools to tackle medication management, med risk-assessments
By
Aaron Dorman
Feb 15, 2024
PointClickCare announced the creation of a new digital platform, Pharmacy Connect, and a new partnership with SinguLab, for med management.